Literature DB >> 20064075

Engineering cytochrome P450 biocatalysts for biotechnology, medicine and bioremediation.

Santosh Kumar1.   

Abstract

IMPORTANCE OF THE FIELD: Cytochrome P450 enzymes comprise a superfamily of heme monooxygenases that are of considerable interest for the: i) synthesis of novel drugs and drug metabolites; ii) targeted cancer gene therapy; iii) biosensor design; and iv) bioremediation. However, their applications are limited because cytochrome P450, especially mammalian P450 enzymes, show a low turnover rate and stability, and require a complex source of electrons through cytochrome P450 reductase and NADPH. AREAS COVERED IN THIS REVIEW: In this review, we discuss the recent progress towards the use of P450 enzymes in a variety of the above-mentioned applications. We also present alternate and cost-effective ways to perform P450-mediated reaction, especially using peroxides. Furthermore, we expand upon the current progress in P450 engineering approaches describing several recent examples that are utilized to enhance heterologous expression, stability, catalytic efficiency and utilization of alternate oxidants. WHAT THE READER WILL GAIN: The review provides a comprehensive knowledge in the design of P450 biocatalysts for potentially practical purposes. Finally, we provide a prospective on the future aspects of P450 engineering and its applications in biotechnology, medicine and bioremediation. TAKE HOME MESSAGE: Because of its wide applications, academic and pharmaceutical researchers, environmental scientists and healthcare providers are expected to gain current knowledge and future prospects of the practical use of P450 biocatalysts.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20064075      PMCID: PMC2811222          DOI: 10.1517/17425250903431040

Source DB:  PubMed          Journal:  Expert Opin Drug Metab Toxicol        ISSN: 1742-5255            Impact factor:   4.481


  150 in total

Review 1.  Plant cytochromes P450: tools for pharmacology, plant protection and phytoremediation.

Authors:  Marc Morant; Søren Bak; Birger Lindberg Møller; Danièle Werck-Reichhart
Journal:  Curr Opin Biotechnol       Date:  2003-04       Impact factor: 9.740

2.  Rational engineering of human cytochrome P450 2B6 for enhanced expression and stability: importance of a Leu264->Phe substitution.

Authors:  Santosh Kumar; Yonghong Zhao; Ling Sun; Surendra S Negi; James R Halpert; B K Muralidhara
Journal:  Mol Pharmacol       Date:  2007-08-22       Impact factor: 4.436

3.  Cytochrome P450 BM-3 evolved by random and saturation mutagenesis as an effective indole-hydroxylating catalyst.

Authors:  Hong-mei Li; Le-he Mei; V B Urlacher; R D Schmid
Journal:  Appl Biochem Biotechnol       Date:  2008-01       Impact factor: 2.926

4.  High-throughput measurement of protein stability in microtiter plates.

Authors:  Jean P Aucamp; Ana M Cosme; Gary J Lye; Paul A Dalby
Journal:  Biotechnol Bioeng       Date:  2005-03-05       Impact factor: 4.530

Review 5.  Exploring the potential of xenobiotic-metabolising enzymes as biocatalysts: evolving designer catalysts from polyfunctional cytochrome P450 enzymes.

Authors:  Elizabeth M J Gillam
Journal:  Clin Exp Pharmacol Physiol       Date:  2005-03       Impact factor: 2.557

6.  Identification of amino acid residues involved in 4-chloroindole 3-hydroxylation by cytochrome P450 2A6 using screening of random libraries.

Authors:  Zhi-Gang Zhang; Yan Liu; F Peter Guengerich; Johannes H Matse; Jun Chen; Zhong-Liu Wu
Journal:  J Biotechnol       Date:  2008-10-15       Impact factor: 3.307

Review 7.  Cytochrome P450 gene-directed enzyme prodrug therapy (GDEPT) for cancer.

Authors:  Ling Chen; David J Waxman
Journal:  Curr Pharm Des       Date:  2002       Impact factor: 3.116

8.  Laboratory evolution of cytochrome p450 BM-3 monooxygenase for organic cosolvents.

Authors:  Tuck Seng Wong; Frances H Arnold; Ulrich Schwaneberg
Journal:  Biotechnol Bioeng       Date:  2004-02-05       Impact factor: 4.530

9.  2,2',5,5'-Tetrachlorobiphenyl: isolation and identification of metabolites generated by rat liver microsomes.

Authors:  B D Preston; J R Allen
Journal:  Drug Metab Dispos       Date:  1980 Jul-Aug       Impact factor: 3.922

Review 10.  Cytochrome p450 and chemical toxicology.

Authors:  F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2007-12-06       Impact factor: 3.739

View more
  27 in total

1.  Rational engineering of the fungal P450 monooxygenase CYP5136A3 to improve its oxidizing activity toward polycyclic aromatic hydrocarbons.

Authors:  Khajamohiddin Syed; Aleksey Porollo; David Miller; Jagjit S Yadav
Journal:  Protein Eng Des Sel       Date:  2013-07-31       Impact factor: 1.650

2.  Enzyme/Prodrug Systems for Cancer Gene Therapy.

Authors:  Obeid M Malekshah; Xuguang Chen; Alireza Nomani; Siddik Sarkar; Arash Hatefi
Journal:  Curr Pharmacol Rep       Date:  2016-10-19

Review 3.  Use of chemical auxiliaries to control p450 enzymes for predictable oxidations at unactivated C-h bonds of substrates.

Authors:  Karine Auclair; Vanja Polic
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

Review 4.  Biomolecular engineering for nanobio/bionanotechnology.

Authors:  Teruyuki Nagamune
Journal:  Nano Converg       Date:  2017-04-24

5.  Pareto Optimization of Combinatorial Mutagenesis Libraries.

Authors:  Deeptak Verma; Gevorg Grigoryan; Chris Bailey-Kellogg
Journal:  IEEE/ACM Trans Comput Biol Bioinform       Date:  2018-07-23       Impact factor: 3.710

Review 6.  Controlling substrate specificity and product regio- and stereo-selectivities of P450 enzymes without mutagenesis.

Authors:  Vanja Polic; Karine Auclair
Journal:  Bioorg Med Chem       Date:  2014-06-25       Impact factor: 3.641

7.  Specific packaging and circulation of cytochromes P450, especially 2E1 isozyme, in human plasma exosomes and their implications in cellular communications.

Authors:  Santosh Kumar; Namita Sinha; Kelli A Gerth; Mohammad A Rahman; Murali M Yallapu; Narasimha M Midde
Journal:  Biochem Biophys Res Commun       Date:  2017-07-26       Impact factor: 3.575

Review 8.  As a painkiller: a review of pre- and postnatal non-steroidal anti-inflammatory drug exposure effects on the nervous systems.

Authors:  Kıymet Kubra Yurt; Suleyman Kaplan
Journal:  Inflammopharmacology       Date:  2017-12-27       Impact factor: 4.473

Review 9.  Cytochrome P450: taming a wild type enzyme.

Authors:  Sang Taek Jung; Ryan Lauchli; Frances H Arnold
Journal:  Curr Opin Biotechnol       Date:  2011-03-14       Impact factor: 9.740

10.  Pyran formation by an atypical CYP-mediated four-electron oxygenation-cyclization cascade in an engineered aureothin pathway.

Authors:  Martin Richter; Benjamin Busch; Keishi Ishida; Bradley S Moore; Christian Hertweck
Journal:  Chembiochem       Date:  2012-09-07       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.